CD274 and neoplasm: Inhibited local tumor recurrence and metastasis, induced tumor immunogenic cell death, promoted antitumor immune response, tracked and eliminated circulating tumor cells, impaired PD-1/PD-L1 pathway, restored the tumor-killing effect of cytotoxic T cells, improved tumor immune microenvironment